Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00462202
Status:
TERMINATED
Last Update Posted:
2017-03-03
First Post:
2007-04-16
Brief Title:
Open Label Tolerability and Safety Study of KRX-101 in Australia New Zealand and Hong Kong
Sponsor:
Keryx Biopharmaceuticals
Organization:
Keryx Biopharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Diabetic Nephropathy |